• 1. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 2. An approach to asymmetric synthesis of β-aryl alanines by Pd(0)-catalyzed cross-coupling and cyanate-to-isocyanate rearrangement?
  Piotr Szcze?niak,Sebastian Stecko RSC Adv., 2015,5, 30882-30888
• 3. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 4. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to 2-(carbamoylamino)pentanoic acid (CAS No. 55512-99-7)

2-(carbamoylamino)pentanoic acid, identified by the Chemical Abstracts Service Number (CAS No.) 55512-99-7, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and biochemistry. This compound, characterized by its unique structural framework, exhibits a blend of functionalities that make it a promising candidate for various biochemical applications. The presence of both carbamoylamino and pentanoic acid moieties imparts distinct reactivity and potential biological activity, positioning it as a subject of intense research interest.

The molecular structure of 2-(carbamoylamino)pentanoic acid consists of a five-carbon chain terminated by a carboxylic acid group, with an amine substituent further modified by a carbamoyl group. This configuration allows for multiple possible interactions with biological targets, including enzymes and receptors, which has sparked investigations into its pharmacological properties. The compound’s dual amine functionality provides opportunities for further derivatization, enabling the synthesis of analogs with tailored biological activities.

In recent years, the pharmaceutical industry has shown increasing interest in compounds that exhibit modulatory effects on metabolic pathways. 2-(carbamoylamino)pentanoic acid has been explored as a potential regulator in processes such as amino acid metabolism and energy homeostasis. Preliminary studies suggest that this compound may influence key enzymes involved in glucose and lipid metabolism, making it a candidate for therapeutic intervention in metabolic disorders. The pentanoic acid moiety, in particular, is recognized for its role in fatty acid biosynthesis and degradation, further enhancing the compound’s relevance in metabolic research.

One of the most compelling aspects of 2-(carbamoylamino)pentanoic acid is its potential as a scaffold for drug discovery. The structural flexibility offered by its backbone allows chemists to modify various functional groups while retaining core biological activity. This characteristic has led to several innovative synthetic strategies aimed at optimizing its pharmacokinetic properties and enhancing target specificity. Researchers have employed computational modeling and high-throughput screening techniques to identify derivatives with improved efficacy and reduced toxicity.

The compound’s interaction with biological systems has also been studied from a mechanistic perspective. Investigations have focused on understanding how 2-(carbamoylamino)pentanoic acid binds to its putative targets and modulates their function. Advanced spectroscopic techniques such as nuclear magnetic resonance (NMR) spectroscopy and X-ray crystallography have been instrumental in elucidating its binding mode. These studies have revealed insights into the compound’s ability to inhibit certain enzymes, which could have implications for treating conditions associated with enzyme overactivity.

Furthermore, the application of 2-(carbamoylamino)pentanoic acid in biomimetic chemistry has been explored. Its structural features make it suitable for designing molecules that mimic natural biomolecules, such as amino acids or peptides. Such mimics are valuable tools in drug design, as they can serve as probes to understand biological processes or as lead compounds for developing new therapeutics. The ability to incorporate this compound into larger molecular frameworks has opened up new avenues for synthetic chemistry.

Recent advancements in green chemistry have also influenced the synthesis of 2-(carbamoylamino)pentanoic acid. Researchers are increasingly adopting environmentally friendly methodologies to produce this compound with minimal waste and energy consumption. Techniques such as catalytic asymmetric synthesis and solvent-free reactions have been employed to streamline the synthetic route while maintaining high yields and purity. These efforts align with broader industry trends toward sustainable pharmaceutical manufacturing.

The potential therapeutic applications of 2-(carbamoylamino)pentanoic acid extend beyond metabolic disorders. Preliminary data suggest that it may have anti-inflammatory properties, making it relevant for investigating novel treatments for chronic inflammatory conditions. The compound’s ability to modulate immune responses could be exploited to develop immunomodulatory agents that target specific pathways involved in inflammation. Such discoveries would contribute significantly to the treatment of diseases where inflammation plays a critical role.

In conclusion, 2-(carbamoylamino)pentanoic acid (CAS No. 55512-99-7) represents a fascinating subject of study in pharmaceutical chemistry and biochemistry. Its unique structural features and demonstrated biological activity position it as a valuable tool for drug discovery and metabolic research. As scientific understanding continues to evolve, further exploration of this compound is expected to yield novel insights into biochemical pathways and therapeutic strategies.

• 121080-96-4(D-Homocitrulline)
• 923-37-5(N-Carbamoyl-DL-aspartic Acid)
• 1188-38-1(Carglumic Acid)
• 33965-42-3((S)-2-Acetamido-5-ureidopentanoic acid)
• 13594-51-9((R)-2-amino-5-ureidopentanoic acid)
• 1190-49-4(L-Homocitrulline)
• 40860-26-2(2-(carbamoylamino)pentanedioic Acid)
• 372-75-8(L-Citrulline)
• 627-77-0(2-Amino-5-ureidopentanoic acid)
• 26117-19-1(3-Methyl-2-ureido-pentanoic Acid)